{"name": "Alnylam Pharmaceuticals",
 "permalink": "alnylam-pharmaceuticals-2",
 "crunchbase_url": "http://www.crunchbase.com/company/alnylam-pharmaceuticals-2",
 "homepage_url": "http://www.alnylam.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "617-551-8200",
 "description": "",
 "created_at": "Tue Mar 29 02:51:50 UTC 2011",
 "updated_at": "Wed Aug 29 03:42:22 UTC 2012",
 "overview": "\u003Cp\u003EAlnylam is developing an entirely new class of innovative medicines based on a breakthrough discovery in biology known as RNA interference, or RNAi. With RNAi technology, we have the opportunity to treat disease and impact the lives of patients in a fundamentally new way by silencing disease-causing genes upstream of today\u0026#8217;s medicines.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       40],
      "assets/images/resized/0012/8181/128181v1-max-150x150.png"],
     [[173,
       47],
      "assets/images/resized/0012/8181/128181v1-max-250x250.png"],
     [[173,
       47],
      "assets/images/resized/0012/8181/128181v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "John",
      "last_name": "Maraganore",
      "permalink": "john-maraganore",
      "image": null}},
   {"is_past": false,
    "title": "President and COO",
    "person":
     {"first_name": "Barry",
      "last_name": "Greene",
      "permalink": "barry-greene-2",
      "image": null}},
   {"is_past": false,
    "title": "Board Member",
    "person":
     {"first_name": "Kevin",
      "last_name": "Starr",
      "permalink": "kevin-starr",
      "image": null}},
   {"is_past": true,
    "title": "Board Director",
    "person":
     {"first_name": "Peter",
      "last_name": "Barrett",
      "permalink": "peter-barrett",
      "image":
       {"available_sizes":
         [[[122,
            150],
           "assets/images/resized/0003/2302/32302v1-max-150x150.jpg"],
          [[180,
            220],
           "assets/images/resized/0003/2302/32302v1-max-250x250.jpg"],
          [[180,
            220],
           "assets/images/resized/0003/2302/32302v1-max-450x450.jpg"]],
        "attribution": "\u003Cp\u003E\u003Ca href=\"http://www.atlasventure.com/ourteam/bio.cfm?id=45\" title=\"Atlas Ventures\" rel=\"nofollow\"\u003EAtlas Ventures\u003C/a\u003E\u003C/p\u003E"}}},
   {"is_past": true,
    "title": "General Counsel",
    "person":
     {"first_name": "Philip",
      "last_name": "Chase",
      "permalink": "philip-chase",
      "image":
       {"available_sizes":
         [[[124,
            124],
           "assets/images/resized/0027/1417/271417v1-max-150x150.jpg"],
          [[124,
            124],
           "assets/images/resized/0027/1417/271417v1-max-250x250.jpg"],
          [[124,
            124],
           "assets/images/resized/0027/1417/271417v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$10M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.masshightech.com/stories/2011/03/28/daily4-Alnylam-lands-10M-pay-from-Takeda.html",
    "source_description": "Alnylam lands $10M pay from Takeda",
    "raised_amount": 10000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 3,
    "funded_day": 28,
    "investments":
     [{"company":
        {"name": "Takeda Pharmaceutical",
         "permalink": "takeda-pharmaceutical",
         "image":
          {"available_sizes":
            [[[82,
               32],
              "assets/images/resized/0005/9044/59044v2-max-150x150.png"],
             [[82,
               32],
              "assets/images/resized/0005/9044/59044v2-max-250x250.png"],
             [[82,
               32],
              "assets/images/resized/0005/9044/59044v2-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "300 Third Street",
    "address2": "3rd Floor",
    "zip_code": "02142",
    "city": "Cambridge",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "promoted Akshay K. Vaishnaw, M.D., Ph.D., to the new position of chief medical officer",
    "stoned_year": 2011,
    "stoned_month": 6,
    "stoned_day": 13,
    "source_url": "http://www.masshightech.com/stories/2011/06/13/daily8-Vaishnaw-named-medical-officer-at-Alnylam.html",
    "source_text": null,
    "source_description": "Vaishnaw named medical officer at Alnylam",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Alnylam Pharmaceuticals",
      "permalink": "alnylam-pharmaceuticals-2"}},
   {"description": "Alnylam gets $3.2M payment from Glaxo",
    "stoned_year": 2012,
    "stoned_month": 7,
    "stoned_day": 30,
    "source_url": "http://www.masshightech.com/stories/2012/07/30/daily7-Alnylam-gets-32M-payment-from-Glaxo.html",
    "source_text": "",
    "source_description": "Alnylam gets $3.2M payment from Glaxo",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Alnylam Pharmaceuticals",
      "permalink": "alnylam-pharmaceuticals-2"}},
   {"description": "Alnylam reaps $29M harvest in new ag bio deal with Monsanto",
    "stoned_year": 2012,
    "stoned_month": 8,
    "stoned_day": 28,
    "source_url": "http://www.fiercebiotech.com/story/alnylam-reaps-29m-harvest-new-ag-bio-deal-monsanto/2012-08-28?utm_source=rss\u0026utm_medium=rss",
    "source_text": "",
    "source_description": "Alnylam reaps $29M harvest in new ag bio deal with Monsanto",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Alnylam Pharmaceuticals",
      "permalink": "alnylam-pharmaceuticals-2"}}],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": null,
   "pub_month": null,
   "pub_day": null,
   "stock_symbol": "NASDAQ:ALNY"},
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}